PSEUDOMYXOMA PERITONEI
Clinical trials for PSEUDOMYXOMA PERITONEI explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMYXOMA PERITONEI trials appear
Sign up with your email to follow new studies for PSEUDOMYXOMA PERITONEI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Matched conditions: PSEUDOMYXOMA PERITONEI
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
What does recovery really look like after aggressive peritoneal cancer surgery?
Knowledge-focused TerminatedThis study follows people with colorectal cancer that has spread to the lining of the abdomen (peritoneal metastasis) or with pseudomyxoma peritonei, a rare tumor of the abdominal cavity. Participants undergo cytoreductive surgery to remove all visible tumors, followed by intrape…
Matched conditions: PSEUDOMYXOMA PERITONEI
Sponsor: Kyungpook National University Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC